OppenheimJ.J and RuscettiF.W.1997. Cytokines. In Medical Immunology, 9th ed. StitesD.P., TerrA.I. and ParslowT.G.Appleton and Lange Stamford, Connecticut, p. 146.
2.
AbbasA.K., LichtmanA.H. and PoberJ.S.1991. Cells and tissues of the immune system. In Cellular and Molecular Immunology.AbbasA.K., ed. W.B. Saunders CompanyPhiladelphia, p. 14.
3.
Sodin-SemrlS., SpagnoloA., MikusR., BarbaroB., VargaJ. and FioreS.2004. Lipoxin A4 and serum amyloid A elicit opposite interleukin-8 and NF-κB> responses via the common ALX receptor.Int. J. Immunopathol. Pharmacol.17:145.
4.
Lo IaconoM., CavalloF., QuaglinoE., RollaS., IezziM., PupaS. M., De GiovanniC., LolliniP-L., MusianiP., ForniG. and CalogeroR. A.2005. A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in her-2/neu transgenic mice.Int. J. Immunopathol. Pharmacol.18:351.
5.
KempurajD., DonelanJ., FrydasS., IezziT., ContiP., BoucherW., PapadoopoulouN. G., MadhappanB., LetourneauL., SabatinoG. and TheoharidesT.C.2004. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities.Int. J. Immunopathol. Pharmacol.17:103.
6.
KempurajD., FrydasS., KaragouniE., HatzistilianouM., BoscoloP., FerroF., Di GiannantonioM., ContiC.M.V., MerlittiD.DoyleR., PetrarcaC., CastellaniM.L. and TheoharidesT.C.2004. Cytokines and the brain.Int. J. Immunopathol. Pharmacol.17:229.
7.
DiacoM., AncaraniF., MontaltoM., VerrecchiaE., EvoliA., ServideiS., GasbarriniG. and MannaR.2004. Association of myasthenia gravis and antisynthetase syndrome: a case report.Int. J. Immunopathol. Pharmacol.17:395.
8.
MarchisioM., SabatinoG.M., AlbaneseA., SantavenereE., BuonaguidiR. and MisciaS.2004. Novel evidence of PLC d2 involvement in the regulation of the differential evolution of human aneurysms.Int. J. Immunopathol. Pharmacol.17:381.
9.
PeeneI., De RyckeL., BaetenD., HoffmanI., VeysE.M. and De KeyserF.2004. History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis.Int. J. Immunopathol. Pharmacol.17:107.
10.
FranchiC., CainelliG., FrigerioE., GaruttiC. and AltomareG.F.2004. Association of Cyclosporine and 311 nm UVB in the treatment of moderate to severe forms of psoriasis: a new strategic approach.Int. J. Immunopathol. Pharmacol.17:401.
11.
MastrangeloF., PiccirilliM., DolciM., TetéS., SperanzaL., PatrunoA., GizziF., FelacoM., ArteseL. and De LutiisM.A.2005. Vascular endothelial growth factor (VEGF) in human tooth germ center.Int. J. Immunopathol. Pharmacol.18:587.
12.
KalogeromitrosD., KempurajD., Katsarou-KatsariA., GregoriouS., MakrisM., BoucherW. and TheoharidesT.C.2005. Theophylline as “add-on” therapy in patients with delayed pressure urticaria: a prospective self-controlled study.Int. J. Immunopathol. Pharmacol.18:595.
13.
DillonS.R., SprecherC., HammondA., 2004. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.Nat. Immunol.5:752.
14.
DreuwA., RadtkeS., PflanzS., 2004. Characterization of the signaling capacities of the novel gp130-like cytokine receptor.J. Biol. Chem.279:36112.
15.
MatalonR., SurendranS., McDonaldJ.D., OkoroduduA.O., TyringS.K., Michals-MatalonK. and HarrisP.2005. Abnormal expression of genes associated with development and inflammationInt. J. Immunopathol. Pharmacol.18:557.
16.
LiuQ. and HamblinM. R.2005. Macrophage-targeted photodynamic therapy: scavenger receptor expression and activation stateInt. J. Immunopathol. Pharmacol.18:391.
17.
OttonelloL., BertolottoM., MontecuccoF., DapinoP. and DallegriF.2005. Dexamethasone - induced apoptosis of human monocytes exposed to immune complexes. Intervention of CD95- and XIAP-dependent pathwaysInt. J. Immunopathol. Pharmacol.18:403.
18.
CrossM. L.2004. Immune-signalling by orally-delivered probiotic bacteria: effects on common mucosal immunoresponses and protection at distal mucosal sites.Int. J. Immunopathol. Pharmacol.17:127
19.
MarinovaS., NenkovP., MarkovaR., NikolaevaS., KostadinovaR., MitovI. and VretenarskaM.2005. Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections.Int. J. Immunopathol. Pharmacol.18:457.
20.
MoseleyT.A., HaudenschildD.R., RoseL. and ReddiAH.2003. Interleukin-17 family and IL-17 receptors.Cytokine Growth Factor Rev.14:155.
21.
MontaltoM., SantoroL., VastolaM., CuriglianoV., RicciR., VecchioF.M., MannaR. and GasbarriniG.2005. Normalisation of high CA 19–9 values in autoimmune hepatitis after steroidal treatment.Int. J. Immunopathol. Pharmacol.18:603.
22.
EspositoI., PernaF., PonticielloA., PerrellaM., GilliM. and SanduzziA.2005. Natural killer cells in baland peripheral blood of patients with idiopathic pulmonary fibrosis (IPF).Int. J. Immunopathol. Pharmacol.18:541.
23.
GorbunovN.V., McFaulS.J., JanuszkiewiczA. and AtkinsJ.L.2005. Pro-inflammatory alterations and status of blood plasma iron in a model of blast-induced lung trauma.Int. J. Immunopathol. Pharmacol.18:547.
24.
BalleriniP., CiccarelliR., CaciagliF., RathboneM.P., WerstiukE.S., TraversaU., BuccellaS., GiulianiP., JiangS., NargiE., VisiniD., SantavenereC. and Di IorioP.2005. P2X7 receptor activation in rat brain cultured astrocytes increases the biosynthetic release of cysteinyl leukotrienesInt. J. Immunopathol. Pharmacol.18:417.
25.
D'HaeneN., MarisC., SandrasF., DehouM.-F., RemmelinkM., DecaesteckerC. and SalmonI.2005. The differential expression of Galectin-1 and Galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomasInt. J. Immunopathol. Pharmacol.18:431.
26.
BonsiL., PierdomenicoL., BiscardiM., MarchionniC., GavazziS., FossariV., GhinassiB., AlvianoF., RondelliD., FranchinaM., BagnaraG.P. and GrossiA.2005. Constitutive and stimulated production of VEGF by human megakaryoblastic cell lines: effect on proliferation and signaling pathwayInt. J. Immunopathol. Pharmacol.18:445.
27.
CavalieriB., MoscaM., RamadoriP., PerrelliM.-G., De SimoneL., ColottaF., BertiniR., PoliG. and CutrinJ.C.2005. Neutrophil recruitment in the reperfused-injured rat liver was effectively attenuated by repertaxin, a novelallosteric noncompetitive inhibitor of CXCL8 receptors: a therapeutic approach for the treatment of post-ischemic hepatic syndromesInt. J. Immunopathol. Pharmacol.18:475.
28.
PetrarcaC., FrydasS., DonelanJ., BoucherW., PapadopoulouN., CaoJ., CastellaniM.L., ContiP., ToniatoE., RobuffoI., VecchietJ., IezziT., MadhappanB. and KempurajD.2005. Interleukin 27 (IL-27): a novel pleiotropic cytokine involved in T cell differentiation and T cell response modulation.Int. J. Immunopathol. Pharmacol.18:191.
29.
Appert-CollinA., DuongF.H.T., Passilly DeGraceP., BennasrouneA., PoindronP., WaiterJ-M. and GiesJ.P.2005. Xaliproden (SR57746A) induces 5-HT1A receptors-mediated Map kinase activation in PC 12 cells.Int. J. Immunopathol. Pharmacol.18:233.
30.
BrunettiL., Di NisioC., OrlandoG., FerranteC. and VaccaM.2005. The regulation of feeding: a cross talk between peripheral and central signalling.Int. J. Immunopathol. Pharmacol.18:201.
31.
TrubianiO., Di PrimioR., TrainiT., PizzicannellaJ., ScaranoA., PiattelliA. and CaputiS.2005. Morphological and cytofluorimetric analysis of adult mesenchymal stem cells expanded ex vivo from periodontal ligament.Int. J. Immunopathol. Pharmacol.18:213.
32.
RiccioniG., Di PietroV., StanisciaT., De FeudisL., TraisciG., CapaniF., FerraraG., Di lifoE., Di TanoG. and D'OrazioN.2005. Community acquired pneumonia in internal medicine: a one-year retrospective study based on pneumonia severity index.Int. J. Immunopathol. Pharmacol.18:575.
33.
MartiniF., AgratiC., D'OffiziG. and PocciaF.2005. HLA-E Up-regulation induced by HTV infection may directly contribute to CD94-mediated impairment of NK cells.Int. J. Immunopathol. Pharmacol.18:26925.
34.
AlexandrakisM.G., PassamF.H., PappaC.A., DamilakisJ., TsirakisG., KandidakiE., StathopoulosE.N. and KyriakouD.S.2005. Serum evaluation of angiogenic cytokines basic fibroblast growth factor, hepatocyte growth factor and TNF-α in patients with myelodysplastic syndromes: correlation with bone marrow microvascular density.Int. J. Immunopathol. Pharmacol.18:287.
35.
FioritiD., DegenerA.M., MischitelliM., VidettaM., ArancioA., SicaS., SoràF. and PietropaoloV.2005. BKV infection and hemorrhagic cystitis after allogeneic bone marrow transplant.Int. J. Immunopathol. Pharmacol.18:309.
36.
LonghiC., ConteM.P., RanaldiS., PentaM., ValentiP., TinariA., SupertiF. and SegantiL.2005. Apoptotic death of listeria monocytogenes-infected human macrophages induced by lactoferricin B, a bovine lactoferrin-derived peptide.Int. J. Immunopathol. Pharmacol.18:317.
37.
LesmaE., RivaE., GiovanniniM., Di GiulioA.M. and GorioA.2005. Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease lb.Int. J. Immunopathol. Pharmacol.18:297.
38.
Lo IaconoM., CavalloF., QuaglinoE., RollaS., IezziM., PupaS.M., De GiovanniC., LolliniP-L., MusianiP., ForniG. and CalogeroR. A.2005. A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in her-2/neu transgenic mice.Int. J. Immunopathol. Pharmacol.18:351.
39.
RossiR.E. and MonasteroloG.2005. A pilot study of feasibility of ultra-rush (20–25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma.Int. J. Immunopathol. Pharmacol.18:277.